Efficacy of endoscopic ultrasound-guided and endoscopic retrograde cholangiopancreatography-guided biliary drainage for malignant biliary obstruction: a systematic review and meta-analysis
Authors:
- 1 January 2020
- journal article
- review article
- Published by Edizioni Minerva Medica in Minerva Medica
- Vol. 110 (6) , 564-574
Abstract
INTRODUCTION: Endoscopic ultrasound-guided (EUS) biliary drainage was used as an alternative method for patients who failed endoscopic retrograde cholangiopancreatography (ERCP). In recent years, an increasing number of patients was treated with EUS-biliary drainage (BD), but lack of data was available to value the efficacy and safety between EUS and ERCP. Therefore, a review was needed to evaluate the similarities and differences between the two methods and explored whether EUS-guided biliary drainage could be considered as first-line treatment. EVIDENCE ACQUISITION: We searched the Pubmed/Medline, Embase, Web of science, Google scholar, the Cochrane Library and Clinical trials of electronic databases till October 2018 for all English language. Primary outcomes to comparison included technical success, clinical success and adverse events. Secondary outcomes consisted of stent dysfunction requiring reintervention and procedure duration, Data from selected studies were collected to calculate the odds ratios (OR) and standard mean difference (SMD). EVIDENCE SINTHESIS: We searched 469 studies and at last identified 4 eligible trials. These included a total of 428 patients, 215 in the EUS group and 213 in the ERCP group. There was no difference in technical success (OR, 0.95; 95% CI: 0.45-2.02; I-2=0%), clinical success (OR, 0.87; 95% CI: 0.42-1.79; I-2=0%) and adverse events between 2 procedures (OR, 0.76; 95% CI: 0.29-2.00; I-2=55%) but EUS-BD consisted of lower rate of reintervention (OR, 0.30; 95% CI: 0.14-0.63; I-2=0%),and fewer procedure-related adverse events in pancreatitis and cholangitis (OR, 0.14; 95% CI: 0.04-0.51; I-2=0%). There was no difference in length of procedure duration, with a pooled standard mean difference of 0.26 (95% CI: -0.15 to 0.66). CONCLUSIONS: EUS-BD and ERCP-BD in terms of relief of malignant biliary obstruction presented the similarity rate of technical success, clinical success and there is no significant difference in adverse events of two procedures. EUS-BD could be used as a substitute for ERCP-BD, even considered as first-line treatment.Keywords
This publication has 31 references indexed in Scilit:
- Prospective evaluation of a treatment algorithm with enhanced guidewire manipulation protocol for EUS-guided biliary drainage after failed ERCP (with video)Gastrointestinal Endoscopy, 2013
- Complications of Endoscopic Retrograde CholangiopancreatographyGastrointestinal Endoscopy Clinics of North America, 2012
- Prospective Clinical Study of EUS-Guided Choledochoduodenostomy for Malignant Lower Biliary Tract ObstructionAmerican Journal of Gastroenterology, 2011
- A lexicon for endoscopic adverse events: report of an ASGE workshopGastrointestinal Endoscopy, 2010
- Management of difficult bile duct cannulation in ERCPWorld Journal of Gastrointestinal Endoscopy, 2010
- Role of ERCP in acute pancreatitisGastrointestinal Endoscopy, 2002
- Endoscopic Ultrasound-Guided Bilioduodenal Anastomosis: A New Technique for Biliary DrainageEndoscopy, 2001
- An Argument Against Routine Percutaneous Biopsy, ERCP, or Biliary Stent Placement in Patients with Clinically Resectable Periampullary MassesPancreas, 1995
- Randomised trial of endoscopic steriting versus surgical bypass in malignant low bileduct obstructionThe Lancet, 1994
- Usefulness of diagnostic tests for biliary obstructionThe American Journal of Surgery, 1982